Literature DB >> 5699204

Very-low-density lipoprotein in intestinal lymph: evidence for presence of the A protein.

R K Ockner, K J Bloch, K J Isselbacher.   

Abstract

Rat mesenteric lymph very-low-density lipoproteins of intestinal origin contain components which are antigenically identical to plasma high-density lipoprotein. Because the antigenicity of the latter most likely resides in its apoprotein (the A protein), it is concluded that intestinal very-low-density lipoproteins contain the A protein. This and other evidence supports the concept that the intestine is a source of plasma very-low-density lipoprotein.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5699204     DOI: 10.1126/science.162.3859.1285

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

2.  Composition, particle size and role in dietary fat transport of two different lipoproteins of the intestinal lymph.

Authors:  M Boquillon; R Paris; J Clement
Journal:  Lipids       Date:  1972-06       Impact factor: 1.880

3.  Apoprotein B in fasting and postprandial human jejunal mucosa.

Authors:  D Rachmilewitz; J J Albers; D R Saunders
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

4.  The intestine as a source of apolipoprotein A1.

Authors:  R M Glickman; P H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

5.  Lymph chylomicron formation during the inhibition of protein synthesis. Studies of chylomicron apoproteins.

Authors:  R M Glickman; K Kirsch
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

6.  Very low density lipoproteins in intestinal lymph: origin, composition, and role in lipid transport in the fasting state.

Authors:  R K Ockner; F B Hughes; K J Isselbacher
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.